Cipla USA, Inc. is recalling approximately 272,624 bottles of Cinacalcet Hydrochloride (generic Sensipar) tablets in 30 mg, 60 mg, and 90 mg strengths. The recall was initiated because testing detected the presence of N-Nitroso Cinacalcet, a chemical impurity, at levels above the acceptable daily intake limit. While no injuries or adverse events have been reported to date, the product was distributed nationwide to pharmacies and wholesalers.
The tablets contain N-Nitroso Cinacalcet at levels that exceed safety limits set by the FDA. Long-term exposure to this impurity above acceptable levels may increase the risk of cancer.
You have 2 options:
Manufactured by Cipla Ltd., MIDC, Patalganga, India.
Manufactured by Cipla Ltd., MIDC, Patalganga, India.
Manufactured by Cipla Ltd., MIDC, Patalganga, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.